These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16818264)

  • 1. Inactivation of CDKN2A, CDKN2B and MTAP in childhood B-lineage acute lymphobastic leukemia.
    Beverloo HB
    Haematologica; 2006 Jul; 91(7):865B. PubMed ID: 16818264
    [No Abstract]   [Full Text] [Related]  

  • 2. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
    Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
    Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
    Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
    Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homozygous deletion and methylation of p16 and p15 gene in acute leukemia].
    Chen W; Zhang W; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):474-6. PubMed ID: 11721412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
    Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of hypermethylation of p15 gene in patients with acute leukemia by polymerase chain reaction].
    Chen F; Zeng X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):250-2. PubMed ID: 11876990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization.
    Kamath A; Tara H; Xiang B; Bajaj R; He W; Li P
    Cancer Genet Cytogenet; 2008 Jun; 183(2):117-20. PubMed ID: 18503831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deletions and aberrant transcription of p16 and p15 genes in childhood acute lymphoblastic leukemia].
    Fu G; Lu C; Zhang R
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):366-8. PubMed ID: 11721435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
    Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A.
    Kumar R; Khan SP; Joshi DD; Shaw GR; Ketterling RP; Feldman AL
    Pediatr Blood Cancer; 2011 Feb; 56(2):307-10. PubMed ID: 20973102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
    Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
    Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
    Xu H; Zhang H; Yang W; Yadav R; Morrison AC; Qian M; Devidas M; Liu Y; Perez-Andreu V; Zhao X; Gastier-Foster JM; Lupo PJ; Neale G; Raetz E; Larsen E; Bowman WP; Carroll WL; Winick N; Williams R; Hansen T; Holm JC; Mardis E; Fulton R; Pui CH; Zhang J; Mullighan CG; Evans WE; Hunger SP; Gupta R; Schmiegelow K; Loh ML; Relling MV; Yang JJ
    Nat Commun; 2015 Jun; 6():7553. PubMed ID: 26104880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous deletions of CDKN2A are present in all dic(9;20)(p13·2;q11·2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation.
    Zachariadis V; Schoumans J; Barbany G; Heyman M; Forestier E; Johansson B; Nordenskjöld M; Nordgren A
    Br J Haematol; 2012 Nov; 159(4):488-91. PubMed ID: 22994152
    [No Abstract]   [Full Text] [Related]  

  • 16. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
    Williams RT; Sherr CJ
    Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
    Lauten M; Asgedom G; Welte K; Schrappe M; Stanulla M
    Haematologica; 2003 Mar; 88(3):353-4. PubMed ID: 12651279
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
    Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
    Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
    Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
    Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
    Boldrin E; Gaffo E; Niedermayer A; Boer JM; Zimmermann M; Weichenhan D; Claus R; Münch V; Sun Q; Enzenmüller S; Seyfried F; Demir S; Zinngrebe J; Cario G; Schrappe M; Den Boer ML; Plass C; Debatin KM; Te Kronnie G; Bortoluzzi S; Meyer LH
    Blood; 2021 Nov; 138(20):1953-1965. PubMed ID: 34098582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.